2016
HNSCC Biomarkers Derived from Key Processes of Cancerogenesis
RAUDENSKÁ, Martina; Jaromír GUMULEC; Andrew M. FRIBLEY and Michal MASAŘÍKBasic information
Original name
HNSCC Biomarkers Derived from Key Processes of Cancerogenesis
Authors
RAUDENSKÁ, Martina (203 Czech Republic, belonging to the institution); Jaromír GUMULEC (203 Czech Republic, belonging to the institution); Andrew M. FRIBLEY (840 United States of America) and Michal MASAŘÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
Switzerland, Targeting Oral Cancer, p. 115-160, 46 pp. 2016
Publisher
Springer International Publishing
Other information
Language
English
Type of outcome
Chapter(s) of a specialized book
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Switzerland
Confidentiality degree
is not subject to a state or trade secret
Publication form
electronic version available online
RIV identification code
RIV/00216224:14110/16:00088944
Organization unit
Faculty of Medicine
ISBN
978-3-319-27647-2
Keywords in English
Head and neck squamous cell carcinoma
Tags
Changed: 31/1/2017 14:40, Ing. Mgr. Věra Pospíšilíková
Abstract
In the original language
Head and neck squamous cell carcinoma (HNSCC) is one of the most frequent aggressive cancers in humans. Well-known risk factors include HPV infection, tobacco smoking, and alcohol consumption. HNSCC overall survival rate is one of the lowest among human malignancies. The poor prognosis of HNSCC often results from late-stage diagnosis, therapeutic resistance, high rates of recurrence, and frequent metastases to lymph nodes. To date, the TNM classification is still the best evaluation of disease progress; however, this method of staging does not pay attention to the molecular basis of tumorigenesis. An improvement in treatment efficacy and diagnostic capabilities will be realized through a better understanding of the pathogenesis and characteristics of HNSCC, a disease that has come to be characterized by confounding heterogeneity. This chapter is focused on molecular markers derived from key processes of cancero-genesis that are involved in metastasis, treatment resistance, avoidance of immune detection, inflammation, induction of angiogenesis, genome instability, dysregulation of cellular energetics, cell death, cancer stem cell biology, and rearrangement of tissues adjacent to the tumor. We will discuss biomarkers identified at different levels of cellular regulation (DNA, RNA, miRNA, and protein markers).
Links
NT14337, research and development project |
|